Top HPV-Vaccine Researchers Join Those Advising Caution in HPV-Vaccines Gardasil and Cervarix Immunization Dr. Diane Harper was a lead researcher in the development of the HPV vaccine. Her HPV-vaccine trial papers were amongst the first I found when I started researching … [Read more...] about HPV-Vaccine, How We Got Here
Merck
Glaxo Claims Cervarix More Effective Than Gardasil
Glaxo says its HPV shot outperforms Merck's When GlaxoSmithKline announced that it would unveil head-to-head trial data on its HPV vaccine long after the fact and at a lesser-known meeting, folks speculated that the drugmaker might be embarrassed of the trial's outcome. Not … [Read more...] about Glaxo Claims Cervarix More Effective Than Gardasil
GlaxoSmithKline Cervarix Press Release
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference Issued: Friday 8 May 2009, London, UK & Malmö, Sweden Key results from three important studies of the cervical cancer vaccine, Cervarix®, will be available as of today at the 25th International … [Read more...] about GlaxoSmithKline Cervarix Press Release
Financial Analysts Judge Merck and Glaxo Sales Growth
Will New Results on Merck and GSK's HPV Vaccines Ignite Sales Growth? May 10, 2009 | about stocks: GSK / MRK Mike Huckman is CNBC’s Pharmaceutical Reporter covering the drug, biotechnology and medical device industries. Huckman is based at the network’s global headquarters in … [Read more...] about Financial Analysts Judge Merck and Glaxo Sales Growth
M-Words: Merck, Money, Market Share
Merck and Glaxo Fight for Increased HPV-Vaccine Sales HPV vaccines were a hot topic during the 25th International Papillomavirus Conference, held May 8-14 in Malmö, Sweden. In the weeks leading up to the big event, Glaxo’s PR machine has been touting new Cervarix vs. Gardasil … [Read more...] about M-Words: Merck, Money, Market Share